(Q40618698)

22 September 2017

Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector (English)

1 reference

intracellular signaling peptides and proteins

22 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605667

30 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700651

30 March 2024

author name string

Semyon Rubinchik

1

1 reference

22 September 2017

Hong Yu

2

1 reference

22 September 2017

Jan Woraratanadharm

3

1 reference

22 September 2017

Christina Voelkel-Johnson

4

1 reference

22 September 2017

Jian-yun Dong

6

1 reference

22 September 2017

James S. Norris

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605667

30 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14605667

30 March 2024

publication date

1 November 2003

1 reference

full work available at URL

22 September 2017

https://www.nature.com/articles/7700651.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605667

https://www.nature.com/articles/7700651

30 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700651

https://www.nature.com/articles/7700651.pdf

30 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700651

30 March 2024

1 reference

22 September 2017

10

1 reference

22 September 2017

814-822

1 reference

22 September 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700651

22 September 2017

0 references

cites work

Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Potentials and limitations of adenovirus-p53 gene therapy for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Adenovirus-mediated p53 gene therapy for human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Death receptor ligands, in particular TRAIL, to overcome drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Modularity in the TNF-receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Cell death induction by receptors of the TNF family: towards a molecular understanding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Activation-induced death of mature T cells in the regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Cell-mediated cytotoxic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Apoptosis control by death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Death by design: mechanism and control of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Proteases for cell suicide: functions and regulation of caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Mammalian caspases: structure, activation, substrates, and functions during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

On the TRAIL to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

The potential of TRAIL for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Nature's TRAIL--on a path to cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Induction of apoptosis in glioma cells by recombinant human Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Construction, purification and characterization of adenovirus vectors expressing apoptosis-inducing transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Differential calcium response in HeLa and HeLa-Fas cells by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Regulation of Fas gene expression in HeLa cells as determined by modified RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Transcriptional activation by tetracyclines in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

The role of caspase-8 in resistance to cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Inhibition of death receptor signals by cellular FLIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: effects of dibutyryl adenosine 3',5'-cyclic monophosphate, alpha-glycyrrhetinic acid, and cytosine arabinoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

In situ use of suicide genes for therapy of brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

A tale of two trials: selectively replicating herpesviruses for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

TRAIL, Fasl and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

7 January 2021

Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

7 January 2021

Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

7 January 2021

Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

7 January 2021

In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700651

7 January 2021

38

57

3941

OW Rokhlin

1997

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700651

30 March 2024

53

62

1583

R Ravi

2002

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700651

30 March 2024

Identifiers

1 reference

Dimensions Publication ID

22 September 2017

0 references

1 reference